Found: 15
Select item for more details and to access through your institution.
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 7, p. 888, doi. 10.1016/j.jalz.2019.04.001
- By:
- Publication type:
- Article
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0328-9
- By:
- Publication type:
- Article
Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0294-2
- By:
- Publication type:
- Article
Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil.
- Published in:
- BMC Neurology, 2009, v. 9, p. 1, doi. 10.1186/1471-2377-9-7
- By:
- Publication type:
- Article
Predicting Long-Term Cognitive Outcome with New Regression Models in Donepezil-Treated Alzheimer Patients in a Naturalistic Setting.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2008, v. 26, n. 3, p. 203, doi. 10.1159/000152911
- By:
- Publication type:
- Article
Donepezil in Alzheimer’s Disease: What to Expect after 3 Years of Treatment in a Routine Clinical Setting.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2007, v. 23, n. 3, p. 150, doi. 10.1159/000098052
- By:
- Publication type:
- Article
The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions.
- Published in:
- European Journal of Human Genetics, 2010, v. 18, n. 11, p. 1202, doi. 10.1038/ejhg.2010.107
- By:
- Publication type:
- Article
Risk Factors for Nursing Home Placement in Alzheimer’s Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment.
- Published in:
- Gerontologist, 2011, v. 51, n. 1, p. 17, doi. 10.1093/geront/gnq050
- By:
- Publication type:
- Article
Risk Factors for Nursing Home Placement in Alzheimer’s Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0174-1
- By:
- Publication type:
- Article
Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.
- Published in:
- Alzheimer's Research & Therapy, 2013, v. 5, n. 5, p. 1, doi. 10.1186/alzrt210
- By:
- Publication type:
- Article
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application.
- Published in:
- Alzheimer's Research & Therapy, 2013, v. 5, n. 1, p. 1, doi. 10.1186/alzrt156
- By:
- Publication type:
- Article
Predictors of long-term cognitive outcome in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2011, v. 3, n. 4, p. 1, doi. 10.1186/alzrt85
- By:
- Publication type:
- Article
Early- versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression.
- Published in:
- Dementia & Geriatric Cognitive Disorders Extra, 2017, v. 7, n. 1, p. 172, doi. 10.1159/000455943
- By:
- Publication type:
- Article